As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: November 8, 2012
by CBC News:
Seniors who take common medications to treat insomnia, anxiety, itching or allergies may have symptoms of forgetfulness or trouble concentrating, a new review concludes.
About 90 per cent of people aged 65 and older take at least one prescription medication and almost half take five or more, studies suggest.
As people increasingly report memory and attention problems and seek testing for early dementia, researchers in Montreal wanted to see how medications can induce such symptoms.
Dr. Cara Tannenbaum, research chair at the Montreal Geriatric University Institute and her co-authors in Montreal, Calgary, Australia and the U.S. reviewed 162 studies on medications most likely to affect memory, creating what’s called an amnesia effect, or affect brain functions like attention and concentration that are called non-amnestic.
“There is a consistent body of evidence suggesting that drug-induced mild cognitive impairment can occur with episodic use of medications for insomnia, anxiety, [itching] or allergy symptoms,” the study’s authors concluded in the journal Drugs & Aging.
“Combined amnestic and non-amnestic deficits occur with the use of benzodiazepine agents and may partially underlie older adults’ frequent complaints of forgetfulness or difficulty concentrating.”
The 68 studies on benzodiazepines, which are often used to treat anxiety and insomnia, showed the drugs consistently lead to impairments in memory and concentration, with higher doses tied to stronger effects.
The 12 tests on antihistamines and the 15 tests on tricyclic antidepressants showed deficits in attention and information processing.
Patients should know this information and feel comfortable talking to their doctors and pharmacists about safer pharmacological or non-pharmacological treatment options, Tannenbaum suggested in a release.
“Despite the known risks, some patients may be better off taking certain drugs when they need them than if the underlying disorder were left untreated,” the researchers wrote.
For non-benzodiazepine drugs, the researchers cautioned that individual molecules may have different properties that should not be lumped together as a class.
The reviewers weren’t able to calculate the magnitude of the effect or how often the cognitive impairments could be expected with each drug class.
Napping for an hour in the afternoon may provide a mental boost for older adults, a new study suggests. This extra daytime sleep was linked to improved memory and ability to think clearly...
The results of recent trials that tested much-anticipated Alzheimer’s disease drugs dashed the hopes of patients with the debilitating condition. The most recent disappointment came from the large trial for solanezumab, by Eli Lilly, announced last...
Treatment with the antibiotic Rocephin (ceftriaxone) may restore brain function in areas affected by Alzheimer’s disease, according to new research. The study, “Mapping Synaptic Glutamate Transporter Dysfunction In Vivo To Regions Surrounding Aβ...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.